Edition:
India

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

18.85USD
16 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$18.85
Open
$17.75
Day's High
$19.25
Day's Low
$17.53
Volume
20,385
Avg. Vol
26,575
52-wk High
$23.81
52-wk Low
$7.74

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $70.42
Shares Outstanding(Mil.): 9.71
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 31.23 33.59
EPS (TTM): -3.21 -- --
ROI: -60.80 15.57 15.05
ROE: -61.05 16.94 16.62

Earnings vs. Estimates